GlycoMimetics (GLYC) Tops Q1 EPS by 3c; Reports Cash and Cash Equivalents of $76.5M

GlycoMimetics (NASDAQ: GLYC) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31). Cash and cash equivalents at March 31, 2022 were $76.5 million.

For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Logitech dips as BofA downgrades stock on demand outlook concerns
• BMW slashes profit margin forecast to 1-3%; JPMorgan calls cut "radical" as stock hits six-year low